The incidence of diabetes is increasing year after year. The increment is also impacting new geographies - in particular developing countries - and it is bringing to pharma manufacturers new challenges and new opportunities.
The rising demand is requiring new players to enter the market to compensate for the request of insulin, both in terms of new manufacturing capacity and efficiency operations. To that end, the price pressure is also pushing for a more efficient supply chain, taking into consideration filling operations, vision inspection, assembly, and packaging.
In parallel, new testing techniques and delivery modalities entered the market, improving the patient’s quality of life and the final user experience.
In this webinar, we present how the integrated approach of Stevanato Group can help to bring innovative and efficient solutions in the diabetes therapeutic area.
Senior Products Platform Leader
Alessandro Morandotti has a background in Electronic Engineering with a Master in Biomedical applications and Devices at the University of Padua. Alessandro Morandotti has been working in the primary packaging field for more than 17 years, focusing on pharmaceutical glass products, combination products, and drug delivery devices.
Member of the PDA in the last years he attended several conferences providing presentations and lectures about primary packaging solutions and he was part of different training sessions, as a teacher, focus on glass primary packaging properties.
He was successfully contributing to developing and commercializing Pre-fillable syringes for Biologic Drug Products.
Thanks to his expertise, his role in Ompi has always been linked to highly technological projects and today is focus on the Development and Promotion of innovative solutions considering the different competences part of the Stevanato Group.